top of page

INTRODUCTION

pc002255487.jpg

BenoBio advances in the development of first-in-class or best-in-class drugs through epigenetic regulation to improve the healthy longevity and the quality of life.

BenoBio believes that the science and technology of epigenetic regulation lead to the development

of first-in-class or best-in-class drugs against inflammatory diseases and cancers. 
Eventually, BenoBio will become a leader as a new global innovator in the treatment for healthy longevity.

301, Building 3, 15, Pangyo-ro 228beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea

​경기도 성남시 분당구 판교로 228번길 15 판교세븐벤처밸리 1단지 3동 301호

Tel: 031-778-8136    Fax: 031-778-8196

Copyright © BenoBio Co., Ltd.

bottom of page